Redmile Group
Venture capital
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
11Deep-tech portfolio6 active
5Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Bambusa Therapeutics
48Co-investorsShare a portfolio company
Portfolio · 11 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Bambusa Therapeutics | Biotech | Active | Feb 26, 2025 | $67.4M |
| Ambrosia Biosciences | Biotech | Active | Aug 20, 2024 | $12.5M |
| Lyell Immunopharma | Biotech | Active | Mar 20, 2020 | $493.0M |
| Korro Bio | Biotech | Active | Jun 7, 2019 | $4.0M |
| Beam Therapeutics | Biotech | Active | Mar 26, 2019 | $180.0M |
| Neuron23 | Biotech | Active | — | — |
| IGM Biosciences | Biotech | Acquired | Jul 7, 2023 | $23.8M |
| Nuvation Bio | Biotech | Public | Oct 20, 2020 | $275.3M |
| Revolution Medicines | Biotech | Public | Nov 15, 2019 | $204.2M |
| Attovia Therapeutics | Biotech | Public | — | — |
| Tempus AI | Medtech | Public | — | — |
Peer ranks
Portfolio size#44
Portfolio exits#40
Raises, 12 months#88
Co-investors#31
Co-investors
- Foresite CapitalVenture capital4 shared
- Cormorant Asset ManagementVenture capital3 shared
- GVVenture capital3 shared
- Boxer CapitalVenture capital2 shared
- EcoR1 CapitalVenture capital2 shared
- Goldman Sachs AlternativesVenture capital2 shared
- Needham Capital PartnersVenture capital2 shared
- RA CapitalVenture capital2 shared
- RTW InvestmentsVenture capital2 shared
- Amgen VenturesVenture capital1 shared
Sectors
- Biotech10
- Medtech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.